期刊文献+

人骨髓、脐血CD34^+干细胞体外扩增的树突状细胞的表型及其T细胞刺激活性分析 被引量:7

Phenotype and T Cell Stimulating Activity of Dendritic Cells Expanded from Human Bone Marrow and Cord Blood CD34^(+) Hematopoietic Progenitor Cells
下载PDF
导出
摘要 目的:从人骨髓造血前体细胞体外培养扩增树突状细胞(dendritic cells,DCs),测定其表型及T细胞刺激活性.方法:采用Mini-MACS分离技术,从正常人骨髓、脐血分离CD34^+造血干细胞,体外以重组hGM-CSF,hTNF-α,hIL-3诱导培养2周,流式细胞术检测扩增细胞的表面表型及细胞内IL-12的表达,体外同种混合淋巴细胞反应检测扩增DCs的T细胞刺激活性.结果:从正常人骨髓、脐血分离得到高纯度(>90%)的CD34^+造血干细胞,经重组hGM-CSF,hTNF-α的共同诱导培养,扩增得到大量DCs,加人hIL-3可以进一步增加DCs产量;FACS检测表明,扩增的DCs表达HLA-DR,CD40,CD54,CD80,CD86分子,细胞内有hIL-12的P35,P40亚基的表达;与外周血单核细胞培养生成的DCs相比,由CD34^+干细胞扩增的DCs具有更强的激发同种T细胞增殖的能力.结论:人CD34^+干细胞体外经诱导培养,可以生成大量功能成熟的DCs,从而为进一步开展DCs的基础及临床研究打下了基础. Objective: To expand dendritic cells from human bone marrow and cord blood CD34+ hematopoietic progenitor cells in vitro and analyze their cell surface phenotype and T cell stimulating activity. Methods: CD34+ hematopoietic stem cells were isolated from normal bone marrow or cord blood by mini-MACS and cultured in GM-CSF, TNF-α, rhlL-3 for 2 weeks. Then the phenotype and IL-12 expression of the expanded cells were analysed by FACS. T cell stimulating activity was determined by allo-MLR. Results: Purity of human CD34+ hematopoietic stem cells isolated from normal bone marrow and cord blood was more then 90% . Large amount of DCs could be obtained by culture in presence of hGM-CSF and hTNF-α, More DCs could be obtained when hIL-3 was also added. DCs expressed HLA-DR, CD40, CD54, CD80, CD86. Intracellular cytokine assay by FACS showed that DCs expressed p35 and p40 subunits of IL-12. The proliferation of allo-T cells stimulated by CD34+ stem cell-derived DCs was more potent than that stimulated by peripheral monocyte-derived DCs. Conclusion: Large amount of mature DCs could be generated by in vitro culture of human CD34+ stem cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 1999年第1期22-26,共5页 Chinese Journal of Cancer Biotherapy
基金 国家863重大项目(Z20-01-03)资助
关键词 树突状细胞 造血干细胞 T细胞刺激活性 体外扩增 dendritic cells antigen presenting cells stem cells GM-CSF tumor necrosis factor a interleukin-12
  • 相关文献

参考文献3

二级参考文献1

  • 1曹雪涛,中华医学杂志,1995年,75卷,602页

共引文献103

同被引文献39

  • 1章卫平,曹雪涛,黄欣,王建莉,张明徽,叶天星.基因修饰的树突状细胞融合后的瘤苗抗肿瘤免疫应答的实验研究[J].中华医学杂志,1997,77(1):39-42. 被引量:30
  • 2朱学军.用IL-13基因转染的肿瘤细胞实验性治疗癌症[J].中国肿瘤生物治疗杂志,1997,4(1):19-19. 被引量:2
  • 3朱学军.应用基因枪技术体内细胞因子基因转移可减缓小鼠肿瘤生长[J].中国肿瘤生物治疗杂志,1997,4(1):25-25. 被引量:3
  • 4Levin D,Constant S,Pasqualini T,et al.Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo[J].J Immunol,1993,151:6742.
  • 5Rosenzwaig M,Camus S,Guigon M,et al.The influence of interleukin (IL) 4、 IL 13 and Flt 3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells[J].Exp Hematal,1998,26(1):63-68.
  • 6Schuler G,Steinman RM.Dendritic cells as adjuvants for immune mediated resistance to tumors[J].J Exp Med,1997,86(18):1183-1188.
  • 7Girolomoni G,Ricciardi Castagnoli P.Dendritic cells hold promise for immunotherapy[J].Immunol Today,1997,18:102-107.
  • 8Celluzzi CM,Mayordomo JI,Storkus WJ,et al.Peptide pulsed dendritic cells induce antigen specific CTL mediated protective tumor immunity[J].J Exp Med,1996,183:283-287.
  • 9Nestle FO,Alijagic S,Gilliet M,et al.Vaecination of melanoma patients with paptide or tumor lysate pulsed dendritic cells[J].Nat Med,1998,4(3):328-332.
  • 10Gabrilovich DI,Cunningham HT,Carbone DP.IL 12 and mutant p53 peptide pulsed dendritic cells for the specific immunotherapy of cancer[J].J Immunother Emphasis Tumor Immunol,1996,19(6):414-418.

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部